HK$2.23
+
HK$0.01 (0.45%)
End-of-day quote: 05/17/2024
SEHK:1349
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Annual Report
| Year | Year | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | ||
|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
HK$741.84M | HK$497.69M | HK$621.87M | HK$579.46M | HK$470.90M | HK$415.93M | |
| GM % | Gross Margin % |
|
90.46% | 88.99% | 92.52% | 91.37% | 92.18% | 92.21% | |
| OM | Operating Margin |
|
12.48% | 12.69% | 23.28% | 24.34% | 17.49% | 25.16% | |
| EPS | Earnings Per Share |
|
HK$0.00 | HK$0.16 | HK$0.08 | HK$0.15 | HK$0.14 | HK$0.13 | HK$0.10 |
| Div. | Dividends |
|
HK$0.07 | HK$0.03 | HK$0.05 | HK$0.03 | HK$0.05 | HK$0.00 | |
| PR % | Payout Ratio % |
|
43.75% | 37.50% | 33.33% | 21.43% | 38.46% | 0 | |
| Sha. | Shares |
|
923m | 923m | 923m | 923m | 923m | 923m | |
| OCF | Operating Cash Flow |
|
HK$179.84M | HK$42.71M | HK$140.57M | HK$96.30M | HK$88.36M | HK$89.44M | |
| FCF | Free Cash Flow |
|
HK$140.88M | HK$-12.73M | HK$94.30M | HK$58.05M | HK$44.27M | HK$32.72M | |
| FCFS | Free Cash Flow Per Share |
|
HK$0.15 | HK$-0.02 | HK$0.10 | HK$0.06 | HK$0.05 | HK$0.04 |
